nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical evidence for the first-line treatment of advanced urothelial carcinoma: Current paradigms and emerging treatment options
|
Koufopoulou, Maria |
|
|
89 |
C |
p. |
artikel |
2 |
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published data
|
Passaro, Antonio |
|
|
89 |
C |
p. |
artikel |
3 |
Editorial Board
|
|
|
|
89 |
C |
p. |
artikel |
4 |
Exposure-response modeling of cabozantinib in patients with renal cell carcinoma: Implications for patient care
|
Castellano, Daniel |
|
|
89 |
C |
p. |
artikel |
5 |
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic
|
Vilariño, N. |
|
|
89 |
C |
p. |
artikel |
6 |
Impact of high tumor mutational burden in solid tumors and challenges for biomarker application
|
McNamara, Mairéad G. |
|
|
89 |
C |
p. |
artikel |
7 |
KRAS: From undruggable to a druggable Cancer Target
|
Uprety, Dipesh |
|
|
89 |
C |
p. |
artikel |
8 |
Melanoma brain metastases – Interdisciplinary management recommendations 2020
|
Gutzmer, Ralf |
|
|
89 |
C |
p. |
artikel |
9 |
Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics
|
Fares, Johny E. |
|
|
89 |
C |
p. |
artikel |
10 |
Review of conditioning regimens for haplo-identical donor transplants using post-transplant cyclophosphamide in recipients of G-CSF mobilised peripheral stem cell
|
Patil, Sushrut |
|
|
89 |
C |
p. |
artikel |
11 |
SARS-CoV-2 and cancer: Are they really partners in crime?
|
van Dam, Peter A. |
|
|
89 |
C |
p. |
artikel |
12 |
Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review
|
Uijen, M.J.M. |
|
|
89 |
C |
p. |
artikel |
13 |
The global landscape of drug development for kidney cancer
|
Trapani, D. |
|
|
89 |
C |
p. |
artikel |
14 |
The landscape of new drugs in extranodal NK/T-cell lymphoma
|
Wang, Liang |
|
|
89 |
C |
p. |
artikel |